Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study

OBJECTIVE: β-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Here, we asked how frequently they revert in a cohort of children at risk for type 1 diabetes and whether reversion has any effect on type 1 diabetes risk. RESEARCH DESIGN AND METHODS: Children were up to 10...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Diabetes Care
Hoofdauteurs: Vehik, Kendra, Lynch, Kristian F., Schatz, Desmond A., Akolkar, Beena, Hagopian, William, Rewers, Marian, She, Jin-Xiong, Simell, Olli, Toppari, Jorma, Ziegler, Anette-G., Lernmark, Åke, Bonifacio, Ezio, Krischer, Jeffrey P.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Diabetes Association 2016
Onderwerpen:
Epidemiology/Health Services Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5001144/
https://ncbi.nlm.nih.gov/pubmed/27311490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc16-0181
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items